71 related articles for article (PubMed ID: 38497668)
1. Commensal bacteria calibrate the activation threshold of innate antiviral immunity.
Abt MC; Osborne LC; Monticelli LA; Doering TA; Alenghat T; Sonnenberg GF; Paley MA; Antenus M; Williams KL; Erikson J; Wherry EJ; Artis D
Immunity; 2012 Jul; 37(1):158-70. PubMed ID: 22705104
[TBL] [Abstract][Full Text] [Related]
2. Pathogenic and Apathogenic Strains of Lymphocytic Choriomeningitis Virus Have Distinct Entry and Innate Immune Activation Pathways.
Johnson DM; Khakhum N; Wang M; Warner NL; Jokinen JD; Comer JE; Lukashevich IS
Viruses; 2024 Apr; 16(4):. PubMed ID: 38675975
[TBL] [Abstract][Full Text] [Related]
3. Confounding roles for type I interferons during bacterial and viral pathogenesis.
Carrero JA
Int Immunol; 2013 Dec; 25(12):663-9. PubMed ID: 24158954
[TBL] [Abstract][Full Text] [Related]
4. Complexities of Type I Interferon Biology: Lessons from LCMV.
Suprunenko T; Hofer MJ
Viruses; 2019 Feb; 11(2):. PubMed ID: 30791575
[TBL] [Abstract][Full Text] [Related]
5. High-Affinity-Mediated Viral Entry Triggers Innate Affinity Escape Resulting in Type I IFN Resistance and Impaired T Cell Immunity.
Xu HC; Pandey P; Ward H; Gorzkiewicz M; Abromavičiūtė D; Tinz C; Müller L; Meyer C; Pandyra AA; Yavas A; Borkhardt A; Esposito I; Lang KS; Lang PA
J Immunol; 2024 May; 212(9):1457-1466. PubMed ID: 38497668
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-27R Signaling Mediates Early Viral Containment and Impacts Innate and Adaptive Immunity after Chronic Lymphocytic Choriomeningitis Virus Infection.
Harker JA; Wong KA; Dallari S; Bao P; Dolgoter A; Jo Y; Wehrens EJ; Macal M; Zuniga EI
J Virol; 2018 Jun; 92(12):. PubMed ID: 29593047
[TBL] [Abstract][Full Text] [Related]
7. Role of interferon regulatory factor 7 in T cell responses during acute lymphocytic choriomeningitis virus infection.
Zhou S; Cerny AM; Fitzgerald KA; Kurt-Jones EA; Finberg RW
J Virol; 2012 Oct; 86(20):11254-65. PubMed ID: 22875973
[TBL] [Abstract][Full Text] [Related]
8. Mice deficient in STAT1 but not STAT2 or IRF9 develop a lethal CD4+ T-cell-mediated disease following infection with lymphocytic choriomeningitis virus.
Hofer MJ; Li W; Manders P; Terry R; Lim SL; King NJ; Campbell IL
J Virol; 2012 Jun; 86(12):6932-46. PubMed ID: 22496215
[TBL] [Abstract][Full Text] [Related]
9. Two separate mechanisms of enforced viral replication balance innate and adaptive immune activation.
Shaabani N; Khairnar V; Duhan V; Zhou F; Tur RF; Häussinger D; Recher M; Tumanov AV; Hardt C; Pinschewer D; Christen U; Lang PA; Honke N; Lang KS
J Autoimmun; 2016 Feb; 67():82-89. PubMed ID: 26553386
[TBL] [Abstract][Full Text] [Related]
10. IRF7-dependent type I interferon production induces lethal immune-mediated disease in STAT1 knockout mice infected with lymphocytic choriomeningitis virus.
Li W; Hofer MJ; Jung SR; Lim SL; Campbell IL
J Virol; 2014 Jul; 88(13):7578-88. PubMed ID: 24760883
[TBL] [Abstract][Full Text] [Related]
11. The role of glycosylation patterns of viral glycoproteins and cell entry receptors in arenavirus infection.
Gorzkiewicz M; Cramer J; Xu HC; Lang PA
Biomed Pharmacother; 2023 Oct; 166():115196. PubMed ID: 37586116
[TBL] [Abstract][Full Text] [Related]
12. A dsRNA-binding mutant reveals only a minor role of exonuclease activity in interferon antagonism by the arenavirus nucleoprotein.
Bohn P; Waßmann I; Wendt L; Leske A; Hoenen T; Tews BA; Groseth A
PLoS Pathog; 2023 Jan; 19(1):e1011049. PubMed ID: 36603036
[TBL] [Abstract][Full Text] [Related]
13. Single MHC-I Expression Promotes Virus-Induced Liver Immunopathology.
Xu HC; Huang J; Pandyra AA; Pandey P; Wang R; Zhang Z; Zhuang Y; Gertzen CGW; Münk C; Herebian D; Borkhardt A; Recher M; Gohlke H; Esposito I; Oberbarnscheidt M; Häussinger D; Lang KS; Lang PA
Hepatol Commun; 2022 Jul; 6(7):1620-1633. PubMed ID: 35166071
[TBL] [Abstract][Full Text] [Related]
14. Receptor binding and complex structures of human ACE2 to spike RBD from omicron and delta SARS-CoV-2.
Han P; Li L; Liu S; Wang Q; Zhang D; Xu Z; Han P; Li X; Peng Q; Su C; Huang B; Li D; Zhang R; Tian M; Fu L; Gao Y; Zhao X; Liu K; Qi J; Gao GF; Wang P
Cell; 2022 Feb; 185(4):630-640.e10. PubMed ID: 35093192
[TBL] [Abstract][Full Text] [Related]
15. Heparan sulfate proteoglycans serve as alternative receptors for low affinity LCMV variants.
Volland A; Lohmüller M; Heilmann E; Kimpel J; Herzog S; von Laer D
PLoS Pathog; 2021 Oct; 17(10):e1009996. PubMed ID: 34648606
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
